STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Bausch Health Companies Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Nomura Holdings filed an amended Schedule 13G reporting beneficial ownership of Bausch Health Companies Inc. common shares. Through wholly owned subsidiary Nomura Global Financial Products, Inc., the group reports beneficial ownership of 15,708,085 shares, representing 4.2% of the class.

The filing lists shared voting and dispositive power over 15,708,085 shares and no sole voting or dispositive power. The percentage is based on 370,473,221 shares outstanding as of September 30, 2025, as disclosed by the issuer. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Shared voting and dispositive power represents 15,708,085 Common Shares beneficially owned by Nomura Global Financial Products, Inc. ("NGFP"). NGFP is a wholly owned subsidiary of Nomura Holdings, Inc., which accordingly may be deemed to beneficially own the Common Shares beneficially owned by NGFP. (2) The percent of class is calculated based on 370,473,221 Common Shares outstanding as of September 30, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2025 filed with the SEC on October 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (3) The percent of class is calculated based on 370,473,221 Common Shares outstanding as of September 30, 2025, as reported in the Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2025 filed with the SEC on October 30, 2025.


SCHEDULE 13G



NOMURA HOLDINGS INC
Signature:/s/ Samir Patel
Name/Title:Samir Patel, Managing Director
Date:11/14/2025
NOMURA GLOBAL FINANCIAL PRODUCTS INC
Signature:/s/ Samir Patel
Name/Title:Samir Patel, Authorized Officer
Date:11/14/2025
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Subsidiaries

FAQ

How many BHC shares does Nomura report owning?

Nomura reports beneficial ownership of 15,708,085 common shares of Bausch Health Companies Inc.

What percentage of BHC does this stake represent?

The filing reports 4.2% of the class based on the issuer’s outstanding shares.

What share count was used to calculate the percentage?

The calculation is based on 370,473,221 shares outstanding as of September 30, 2025, per the issuer’s Form 10-Q.

Who are the reporting persons in this Schedule 13G/A for BHC (BHC)?

The reporting persons are Nomura Holdings, Inc. and Nomura Global Financial Products, Inc.

Does Nomura have voting and dispositive power over the BHC shares?

Yes. The filing lists shared voting power and shared dispositive power over 15,708,085 shares, and no sole power.

What does the certification in the filing state?

It states the securities were acquired and are held in the ordinary course of business and not to change or influence control.

What is the date of the event requiring this filing?

The date of the event is September 30, 2025.
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Latest SEC Filings

BHC Stock Data

2.33B
325.05M
10.78%
68.51%
2.23%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Canada
QUEBEC